IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 46 filers reported holding IMPEL NEUROPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,314 | -66.1% | 3,056 | 0.0% | 0.00% | – |
| Q2 2023 | $3,881 | -9.3% | 3,056 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $4,278 | -62.7% | 3,056 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,460 | -23.6% | 3,056 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $15,000 | -46.4% | 3,056 | 0.0% | 0.00% | -40.0% |
| Q2 2022 | $28,000 | +47.4% | 3,056 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $19,000 | -26.9% | 3,056 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $26,000 | +13.0% | 3,056 | +60.8% | 0.00% | -33.3% |
| Q3 2021 | $23,000 | – | 1,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Norwest Venture Partners XIV, LP | 3,077,198 | $27,233,000 | 31.45% |
| 5AM Venture Management, LLC | 2,884,791 | $25,530,000 | 6.42% |
| venBio Partners LLC | 2,759,791 | $24,424,000 | 2.88% |
| LASRY MARC | 330,000 | $2,921,000 | 1.35% |
| Vivo Capital, LLC | 2,884,789 | $25,530,000 | 1.10% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,802,639 | $33,653,000 | 0.14% |
| Woodline Partners LP | 119,615 | $1,059,000 | 0.02% |
| Pinz Capital Management, LP | 6,188 | $55,000 | 0.02% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 230,238 | $2,019,000 | 0.02% |
| Zimmer Partners, LP | 25,000 | $221,000 | 0.00% |